Are We Overprescribing Statins?

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings. The GameChangerAdopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management. GuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadReferenceAtherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events EquationsPrevious GameChangers on PREVENT score Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.0.05 CEU/0.5 HrUAN: 0107-0000-24-245-H01-PInitial release date: 08/12/2024Expiration date: 08/12/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram